These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 36344987)
1. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia. Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial. Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653 [TBL] [Abstract][Full Text] [Related]
3. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
4. North American Study for the Treatment of Recurrent Epistaxis with Doxycycline: The NOSTRIL trial. McWilliams JP; Majumdar S; Kim GH; Lee J; Seals K; Tangchaiburana S; Gilbert S; Duckwiler GR J Thromb Haemost; 2022 May; 20(5):1115-1125. PubMed ID: 35108451 [TBL] [Abstract][Full Text] [Related]
5. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial. Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649 [TBL] [Abstract][Full Text] [Related]
7. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451 [TBL] [Abstract][Full Text] [Related]
8. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT). Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H; J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799 [TBL] [Abstract][Full Text] [Related]
10. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study. Kroon S; Snijder RJ; Hosman AE; Vorselaars VMM; Disch FJM; Post MC; Mager JJ Angiogenesis; 2021 May; 24(2):379-386. PubMed ID: 33211216 [TBL] [Abstract][Full Text] [Related]
11. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Yaniv E; Preis M; Hadar T; Shvero J; Haddad M Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429 [TBL] [Abstract][Full Text] [Related]
12. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis. Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial. Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745 [TBL] [Abstract][Full Text] [Related]
14. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial. Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923 [TBL] [Abstract][Full Text] [Related]
15. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding. Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636 [TBL] [Abstract][Full Text] [Related]
16. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464 [TBL] [Abstract][Full Text] [Related]
17. The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review. Albarki H; Rimmer J Am J Rhinol Allergy; 2022 Nov; 36(6):890-896. PubMed ID: 35929049 [TBL] [Abstract][Full Text] [Related]
18. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia. Parambil JG; Woodard TD; Koc ON Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965 [TBL] [Abstract][Full Text] [Related]
19. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F MAbs; 2014; 6(3):794-9. PubMed ID: 24481211 [TBL] [Abstract][Full Text] [Related]
20. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis. Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]